Outside the JPM Healthcare Conference, Thomas Clozel, cofounder and CEO of Owkin, sat down with MobiHealthNews to discuss how ...
Silicon Valley Bank head of healthcare and life sciences says the bank's strategy has remained the same since its collapse in ...
Michael Abrams of Numerof and Associates says that oversight for AI used in mental health care should mirror that of pharmaceuticals, with clear standards, safety testing and ongoing monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback